CSPC Pharmaceutical Group Limited: all 344 studies

Page 1 of 4. Open to participants first (160), then studies with results posted, then the rest; newest registration first within each.

• Immunogenicity and Safety of SYS6052 in the Participants Aged 40 Years and AboveNot yet recruitingNCT07892989Phase 1/2
• Phase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection.Not yet recruitingNCT07881991Phase 2
• A Study of SYS6043 Versus Investigator's Choice Chemotherapy as First-Line Treatment in Patients With Unresectable Locally Recurrent or Metastatic Triple-Negative Breast CancerNot yet recruitingNCT07879911Phase 3
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6088 in Patients With Advanced/Metastatic Solid TumorsNot yet recruitingNCT07857135Phase 1/2
• Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese ParticipantsNot yet recruitingNCT07840729Phase 1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of SYS6043 ± Bevacizumab ± Chemotherapy in Participants With Advanced Solid TumorsNot yet recruitingNCT07833735Phase 1/2
• A Study of HB1801 Versus Docetaxel (Taxotere®) in Patients With Advanced Breast CancerNot yet recruitingNCT07805135Phase 3
• Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.Not yet recruitingNCT07803991Phase 2
• A Study of SYH2085 Tablets Compared With Placebo in Chinese Adult Patients With Uncomplicated Influenza.Not yet recruitingNCT07798193Phase 2
• A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or MetforminNot yet recruitingNCT07796477Phase 2
• A Study of SYH2092 Injection in Healthy ParticipantsNot yet recruitingNCT07776041Phase 1
• A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food of SYH2056 in Healthy SubjectsNot yet recruitingNCT07771777Phase 1
• Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaNot yet recruitingNCT07761286Phase 1/2
• SYS6010 vs Investigator's Choice of Monotherapy in Patients With Recurrent or Metastatic HNSCCNot yet recruitingNCT07758621Phase 3
• Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Participants.RecruitingNCT07756996Phase 1
• A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal CancerNot yet recruitingNCT07750041Phase 1/2
• A Phase I/IIa Study of SYS6041 in Patients With Advanced Solid TumorsRecruitingNCT07744763Phase 1/2
• A Clinical Study of SYS6041 Combination Therapy for Recurrent Ovarian CancerRecruitingNCT07714668Phase 2
• A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube CancersRecruitingNCT07708753Phase 3
• A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial LesionsNot yet recruitingNCT07702656Phase 2
• A Study of SYH2070 Injection in Participants With Mixed HyperlipidemiaRecruitingNCT07695597Phase 2
• A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal FunctionRecruitingNCT07694869Phase 1
• A Phase I Clinical Trial to Evaluate the Pharmacokinetic and Safety of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Mild Hepatic Impairment, Moderate Hepatic Impairment, and Normal Liver FunctionRecruitingNCT07694843Phase 1
• SYH2095 for Advanced Malignant Tumors: Phase I StudyNot yet recruitingNCT07692776
• A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid HemangioendotheliomaNot yet recruitingNCT07684287Phase 2
• A Multicenter, Open-label, Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics (PK), and Immunogenicity of the Combination Therapy of SYS6026 in the Treatment of Advanced Solid TumorsNot yet recruitingNCT07684261
• A Study of SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)Not yet recruitingNCT07672223Phase 3
• A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 TabletsRecruitingNCT07647783Phase 1
• A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a)Not yet recruitingNCT07640217Phase 2
• A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant HypertensionNot yet recruitingNCT07635914Phase 3
• SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）Not yet recruitingNCT07633873Phase 3
• A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic AcidNot yet recruitingNCT07623915Phase 3
• A Phase III Clinical Trial to Evaluate the Efficacy and Safety of Octreotide Long-acting Injection in Patients With AcromegalyNot yet recruitingNCT07623824Phase 3
• SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in Participants With Advanced Solid TumorsNot yet recruitingNCT07622225Phase 1/2
• A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07600021Phase 2
• A Clinical Study of SYS6023 Combination Therapy for Advanced Breast CancerRecruitingNCT07597629Phase 2
• Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial HypercholesterolemiaRecruitingNCT07591298Phase 2
• A Study of SYS6051 in Subjects With Advanced Solid TumorsNot yet recruitingNCT07591285Phase 1
• A Comparative Pharmacokinetic Study of CM326 in Healthy SubjectsNot yet recruitingNCT07560033Phase 1
• Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.Not yet recruitingNCT07547384Not applicable
• A Study of JSKN003 Versus Trastuzumab in Combination With Pertuzumab and Docetaxel as First-Line Treatment for HER2-Positive Recurrent or Metastatic Breast CancerNot yet recruitingNCT07545044Phase 2
• A Single Ascending Dose and Multiple Ascending Doses Study of SYH2082 Injection in Healthy ParticipantsRecruitingNCT07532655Phase 1
• SYS6002 vs Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial CarcinomaNot yet recruitingNCT07526792Phase 3
• Observational Study to Assess the Safety of rhTNK-tPA (Mingfule®) vs. Rt-PA (Actilyse®) in Treating Acute Ischemic StrokeNot yet recruitingNCT07519889
• Study Evaluating the Safety, Efficacy and Pharmacokinetics of SYH9089 Injection in Patients Undergoing Abdominal Surgery.RecruitingNCT07519109Phase 1
• A Single- and Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2059 Powder for InhalationNot yet recruitingNCT07510958Phase 1
• A Bioequivalence Study of PP3M in Patients With SchizophreniaRecruitingNCT07493551Not applicable
• SYS6090 Combination Therapy in Advanced Lung CancerNot yet recruitingNCT07472647Phase 1/2
• A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)RecruitingNCT07465263Phase 3
• SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase ⅢNot yet recruitingNCT07442565Phase 3
• A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast CancerRecruitingNCT07441460Phase 3
• A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed HyperlipidemiaRecruitingNCT07421297Phase 3
• A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering TherapyNot yet recruitingNCT07421284Phase 3
• A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal PolyposisNot yet recruitingNCT07420257Phase 3
• Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy ParticipantsRecruitingNCT07419698Phase 1
• A Phase II Study of CM326 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingNCT07418736Phase 2
• SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07417735Phase 3
• Phase 1/II Clinical Study of SYS6043 in the Treatment of Advanced/Metastatic Solid TumorsRecruitingNCT07415863Phase 1/2
• A Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2085RecruitingNCT07412353Phase 1
• A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast CancerNot yet recruitingNCT07406542Phase 3
• JSKN003 Versus Physician Choiced Treatment in Patients With HER2-positive and Advanced Colorectal Cancer Who Had Failed to Respond to Oxaliplatin, 5-Fu, and IrinotecanNot yet recruitingNCT07384377Phase 3
• A Phase Ⅲ Clinical Study of SYS6010 in Combination With Osimertinib in Patients With Locally Advanced or Metastatic NSCLCNot yet recruitingNCT07376382Phase 3
• SYS6002 vs PADCEV in Patients With Advanced Urothelial CarcinomaNot yet recruitingNCT07374549Phase 2
• A Phase III Study of CM326 in Subjects With Moderate to Severe AsthmaRecruitingNCT07372287Phase 3
• Immunogenicity and Safety of SYS6017 in the Participants Aged 40 Years and AboveNot yet recruitingNCT07354659Phase 2
• A Study of KN026-based Combination Therapy in HER2-positive Gastric CancerNot yet recruitingNCT07332533Phase 2/3
• Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver CancerNot yet recruitingNCT07282509Phase 1/2
• Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract TumorsRecruitingNCT07280832Phase 1/2
• JMT106 Injection in the Treatment of Advanced Solid TumorsRecruitingNCT07275073Phase 1
• A Study of SYS6010 Combined With Osimertinib Versus Osimertinib Alone as Neoadjuvant Therapy for Patients With EGFR Mutation-positive Resectable Non-squamous Non-small Cell Lung CancerNot yet recruitingNCT07256509Phase 2
• SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell CarcinomaRecruitingNCT07254585Phase 2
• A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.Not yet recruitingNCT07251062Phase 2/3
• A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid TumorsRecruitingNCT07241936Phase 1/2
• A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 InjectionRecruitingNCT07241923Phase 1
• A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061RecruitingNCT07241910Phase 1
• SYS6002 vs Chemotherapy in Recurrent or Metastatic Cervical CancerNot yet recruitingNCT07230626Phase 3
• Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.RecruitingNCT07201688Phase 3
• Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine TumorsRecruitingNCT07165886Phase 2/3
• A Study to Evaluate the Effects and Safety of Hydroxocobalamin in Participants With Combined Methylmalonic Academia (cblC Type)Not yet recruitingNCT07163364Phase 3
• a Phase 1b/2a Study of JMT202 Injection in Participants With HypertriglyceridemiaRecruitingNCT07140809Phase 1/2
• The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal CancerNot yet recruitingNCT07134205Phase 3
• Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver MetastasesRecruitingNCT07117435Phase 1
• HB1801 Combined Treatment of HER2-positive Breast CancerNot yet recruitingNCT07116824Phase 2
• A Clinical Study of SYS6023 in Patients With Advanced Solid TumorsRecruitingNCT07110883Phase 1
• Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer PatientsRecruitingNCT07096869Phase 1
• A Study Comparing the Efficacy and Safety of HB1801 With Taxotere® in Advanced Breast CancerNot yet recruitingNCT07083505Phase 2
• A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous NephropathyNot yet recruitingNCT07029139Phase 2
• JSKN003 Combined Treatment of HER2-positive Gastric CancerNot yet recruitingNCT06998771Phase 2
• SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCCNot yet recruitingNCT06989671Phase 2
• A Study of SYS6040 for Injection in Patients With Advanced Solid TumorsRecruitingNCT06970795Phase 1
• A Trial of Dextromethorphan and Bupropion Sustained-Release Tablets in Patients With Major Depressive DisorderRecruitingNCT06958692Phase 3
• Evaluation of SYS6005 in Patients With Advanced Malignant TumorRecruitingNCT06958679Phase 1
• Safety and Immunogenicity of SYS6017 in Healthy Participants Aged 40 Years or MoreNot yet recruitingNCT06954818Phase 1
• Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid TumorsRecruitingNCT06947291Phase 2
• A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque PsoriasisNot yet recruitingNCT06943950Phase 3
• A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast CancerNot yet recruitingNCT06941142Phase 1
• Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 InhibitorsNot yet recruitingNCT06929325Phase 3
• Phase III Trial of SYS6010 Versus Platinum-based Chemotherapy for EGFR-mutated NSCLC（SYNSTAR01）RecruitingNCT06927986Phase 3
• Glumetinib Combined With Osimertinib Treatment for Non-Small Cell Lung Cancer PatientsNot yet recruitingNCT06908772Phase 2/3
• JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal CancerNot yet recruitingNCT06892431Phase 2

← CSPC Pharmaceutical Group Limited overview and focus areas